PackTalk is a blog for the Healthcare Packaging Industry

ISO 11607 & EU MDR: Getting Clarity on Risk Management


Published on April 29, 2020

A year after the publication of ISO 11607-1/2 revisions, seeking further harmony with 2020’s EU MDR, new changes are in the works.

It’s not news that review of ISO standards for medical device development is perpetual.  Not only does this keep the folks at ISO busy, it keeps those of us adhering to the standards on our toes, too. For the last year, there has been plenty of discussion of changes to ISO 11607 Parts 1 and 2.

The final implementation of the EU MDR this year was a key impetus behind the February 2019 ISO 11607-1/2 update. What has evolved since the release of the update, however, is further scrutiny. Specifically, regulators considered the broad direction of ISO 11607-2: 4.2. The new, brief clause simply states that medical device development activities should “consider risk management to medical devices.” The lack of detail and room for interpretation has been called into question. Ultimately, agreeing some definition was needed, the amending team has embarked on a refinement process.

Full Article on ISO 11607-2 Risk Management


Comments (0)

Related Articles

COVID-19 Testing Supply and Capacity May Be Key to Reopening the Economy

May 29, 2020

Since the first confirmed COVID-19 case reported in the United States in late January, the nation has seen more than 1.6 million confirmed cases and approximately 96 thousand deaths. This number has risen higher than anticipated while states have been staying...

Learn More

Global Medical Device Regulations & Harmonization Efforts of Sterile Medical Pac...

May 29, 2020

We are going through a global health crisis which is unprecedented in our lifetime. This is a global pandemic which requires an international response. As such, it becomes even more important to understand global harmonization of best practices in the...

Learn More

The FDA Authorizes First COVID-19 Saliva-Based Test for Home

May 29, 2020

With COVID-19 test kits in high demand, the FDA has been authorizing new at-home sample collections to help make tests more accessible.

Until this point, all at-home tests have required collection from a patient’s nose using a nasal swab and saline. But,...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.